Loading...
Market
Next milestone for DBS in spinal cord injuries by end of 2025?
2
Resolution / Starting Odds
Full mobility restoration in a patient • 25%
Widespread clinical trials • 25%
FDA approval • 25%
None of the above • 25%
Peer-reviewed journals, medical conferences, and major health news outlets
Story
Deep Brain Stimulation Restores Mobility in Two Paralyzed Patients, Allowing Short Distances and Stair Climbing
Dec 2, 2024, 04:28 PM
Recent advancements in brain stimulation have led to significant breakthroughs in the recovery of mobility for individuals with spinal cord injuries. A pioneering study has demonstrated that deep brain stimulation (DBS) targeting the lateral hypothalamus can restore the ability to walk in two paraplegic patients. These patients were able to walk short distances and even climb stairs after electrodes were implanted in their brains. This innovative approach has shown promising results in both preclinical models and human trials, indicating a potential shift in rehabilitation strategies for spinal cord injury patients.
View original story
Similar markets
Switzerland • 25%
United States • 25%
European Union • 25%
Other • 25%
Yes • 50%
No • 50%
No improvement • 25%
Partial improvement (e.g., short distances) • 25%
Significant improvement (e.g., walking long distances) • 25%
Full mobility restoration • 25%
Yes • 50%
No • 50%
1-2 countries • 25%
3-5 countries • 25%
6-10 countries • 25%
More than 10 countries • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Significant improvement • 25%
Moderate improvement • 25%
No significant improvement • 25%
Worsening of symptoms • 25%
Positive outcome • 25%
Negative outcome • 25%
Inconclusive outcome • 25%
Trial not completed • 25%
FDA approval for commercial use • 25%
Integration with another major tech device • 25%
Partnership with a major tech company • 25%
Clinical trials expansion • 25%
Less than 40% • 25%
40% to 50% • 25%
50% to 60% • 25%
More than 60% • 25%